Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 16, 2003

Book review

Review article

Favourites:
ADD

Cyclophilin D as a Drug Target
pp. 1485-1506(22)
Authors: Waldmeier, Peter C.; Zimmermann, Kaspar; Qian, Ting; Tintelnot-Blomley, Marina; Lemasters, John J.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Hexokinase II: The Integration of Energy Metabolism and Control of Apoptosis
pp. 1535-1551(17)
Authors: Pastorino, John G.; Hoek, Jan B.

Favourites:
ADD

Bcl-2-Related Proteins as Drug Targets
pp. 1553-1562(10)
Authors: O'Neill, Jason W.; Hockenbery, David M.

Favourites:
ADD

The Peripheral Benzodiazepine Receptor: A Promising Therapeutic Drug Target
pp. 1563-1572(10)
Authors: Galiegue, Sylvaine; Tinel, Norbert; Casellas, Pierre

Favourites:
ADD

Mitochondrial Lipids as Apoptosis Regulators
pp. 1573-1580(8)
Authors: Malisan, Florence; Testi, Roberto

Favourites:
ADD

Interferon-γ-Induced Conversion of Tryptophan: Immunologic and Neuropsychiatric Aspects
pp. 1581-1591(11)
Authors: Wirleitner, B.; Neurauter, G.; Schrocksnadel, K.; Frick, B.; Fuchs, D.

Favourites:
ADD

Perspectives on the Cardioprotective Effects of Statins
pp. 1593-1601(9)
Authors: Luo, Jian-Dong; Chen, Alex F.

Favourites:
ADD

Nuclear Factor Kappa B: A Potential Target for Anti-HIV Chemotherapy
pp. 1603-1615(13)
Authors: Pande, V.; Ramos, M. J.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content